Federal Capture Intelligence

Top HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) contractors (NAICS 541715)

Contract actions: October 1, 2021 – September 10, 2026 Updated September 11, 2026 Department of Health and Human Services agency guide NAICS 541715 · Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Latest 12 months
$1.7B
Net obligations · Up $142.1M vs. $1.6B preceding
Prime contractors
227
With positive obligations in the latest 12 months

Research the HHS federal contracting market for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) under NAICS 541715. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, observed contract vehicle usage, and potential recompete research leads.

Contract obligation trends for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services

Federal records show $9.9B in net obligations across 2,640 awards in Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) at the Department of Health and Human Services from Oct 1, 2021 through Sep 10, 2026. This market accounts for 6.8% of $145.5B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations increased 8.9% from $1.6B to $1.7B. 35 prime contractors accounted for at least 80% of positive obligations in that latest period.

Fiscal-year activity

FY26 is year-to-date through Sep 10, 2026; earlier years show complete fiscal-year totals.

FY26 year-to-date: $1.1B versus $786.5M through the same date in FY25 (+36.3%).
Net obligations · complete fiscal yearNet obligations · FY26 YTDContract actions
View fiscal-year data table
Fiscal yearNet obligationsContract actionsCoverage
FY2022$2.1B1,871Complete
FY2023$3.1B1,814Complete
FY2024$2.2B2,036Complete
FY2025$1.4B1,765Complete
FY2026$1.1B1,271YTD through Sep 10, 2026

Market at a glance

All reported prime contract awards
All-period net obligations
$9.9B
2,640 awards · 809 prime contractors
Latest 12-month movement
+8.9%
$1.7B vs. $1.6B
Leading eight prime share
61.9%
Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
Agency context
6.8% of $145.5B in agency-wide net obligations.
Set-aside share when reported
29.0% of 1,362 awards with reported set-aside status.
Set-aside reporting
395 set aside · 967 no set-aside · 1,278 not reported

What changed in the last 12 months?

Sep 11, 2025–Sep 10, 2026, compared with Sep 11, 2024–Sep 10, 2025.

Award activity

Competitive shifts

LEIDOS BIOMEDICAL RESEARCH INC had the largest increase in reported obligations
$572.7M→$701.6M+$128.8M
The contractor now ranks #1 by positive obligations and accounts for 40.2% of positive obligations, based on 168 reported actions.
REVAGENIX INC climbed the most in the contractor rankings
#141→#16Up 125 places
The contractor accounts for 0.81% of positive obligations across 8 reported actions.
SYNEDGEN, INC. fell the most in the contractor rankings
#15→#105Down 90 places
The contractor accounts for 0.11% of positive obligations across 1 reported action.

Buyer demand

Reported obligations through NATIONAL INSTITUTES OF HEALTH NCATS increased
$334K→$107.2M+$106.8M
Latest-period activity spans 16 awards across 6 prime contractors.
Reported obligations through NIH NCI decreased
$708.3M→$642.5M−$65.9M
Latest-period activity spans 157 awards across 57 prime contractors.
View 4 additional material changes

Competitive shifts

24 contractors were first observed in this market during the latest 12 months
$47.8MLatest 12-month obligations
Contractor-level obligations and first-observed dates appear below. “First observed” applies only to this market and the period shown.
View 24 contractors
ContractorLatest 12 months
PARTNER THERAPEUTICS, INC. had no reported activity in the latest 12 months
$13.0M→$0No latest-period activity
It previously ranked #19 by positive obligations, based on 4 reported actions.
GIGAGEN INC had the largest decline in reported obligations
$19.6M→$0−$19.6M
The contractor now is unranked by positive obligations, based on 3 reported actions.
TEMPUS AI, INC was the largest newly observed contractor
$12.6MLatest 12-month obligations
First observed in this market on Sep 17, 2025, the contractor now ranks #18 by positive obligations across 3 reported actions.
How these findings are calculated

Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.

Federal contract obligations by funding office

See how positive obligations were attributed across funding offices in the 12 months ending Sep 10, 2026.

37.0% of positive obligations were attributed to NIH NCI. That represents $642.5M, down $65.9M from the preceding 12 months.

Latest 12-month share of positive obligations; the gray segment represents all other reported offices.

  1. NIH NCI37.0% · $642.5M · down $65.9M
  2. NATIONAL INSTITUTES OF HEALTH NIAID21.7% · $376.1M · up $80.6M
  3. OFC OF ACQUISITION AND GRANTS MGMT7.4% · $127.7M · up $28.3M
  4. NATIONAL INSTITUTES OF HEALTH NHLBI7.0% · $121.8M · up $49.6M
  5. NATIONAL INSTITUTES OF HEALTH NCATS6.2% · $107.2M · up $106.8M
  6. All other reported offices20.7% of positive obligations
View reported office rankings, comparisons, and evidence

USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.

  1. Reported funding office

    NIH NCI

    #1Rank unchanged

    Latest 12 months

    $642.5M

    37.0% of positive obligations

    Versus preceding 12 months

    −$65.9M

    57 active prime contractors · 157 awards

    View office comparison and evidence

    Reported obligations decreased 9.3% from $708.3M to $642.5M. The office’s share of positive obligations moved from 44.5% to 37.0%, a change of −7.5 percentage points.

    The latest period contains 243 actions across 157 awards and 15 newly active prime contractors. The preceding period contained 80 active prime contractors and 187 awards.

    Leading award-level changes

  2. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIAID

    #2Rank unchanged

    Latest 12 months

    $376.1M

    21.7% of positive obligations

    Versus preceding 12 months

    +$80.6M

    83 active prime contractors · 171 awards

    View office comparison and evidence

    Reported obligations increased 27.3% from $295.5M to $376.1M. The office’s share of positive obligations moved from 18.6% to 21.7%, a change of +3.1 percentage points.

    The latest period contains 339 actions across 171 awards and 17 newly active prime contractors. The preceding period contained 104 active prime contractors and 200 awards.

  3. Reported funding office

    OFC OF ACQUISITION AND GRANTS MGMT

    #3Rank unchanged

    Latest 12 months

    $127.7M

    7.4% of positive obligations

    Versus preceding 12 months

    +$28.3M

    1 active prime contractor · 16 awards

    View office comparison and evidence

    Reported obligations increased 28.5% from $99.4M to $127.7M. The office’s share of positive obligations moved from 6.2% to 7.4%, a change of +1.1 percentage points.

    The latest period contains 39 actions across 16 awards. The preceding period contained 2 active prime contractors and 21 awards.

  4. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NHLBI

    #4Up 2 from #6

    Latest 12 months

    $121.8M

    7.0% of positive obligations

    Versus preceding 12 months

    +$49.6M

    48 active prime contractors · 128 awards

    View office comparison and evidence

    Reported obligations increased 68.6% from $72.2M to $121.8M. The office’s share of positive obligations moved from 4.5% to 7.0%, a change of +2.5 percentage points.

    The latest period contains 181 actions across 128 awards and 10 newly active prime contractors. The preceding period contained 49 active prime contractors and 153 awards.

  5. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NCATS

    #5Up 26 from #31

    Latest 12 months

    $107.2M

    6.2% of positive obligations

    Versus preceding 12 months

    +$106.8M

    6 active prime contractors · 16 awards

    View office comparison and evidence

    Reported obligations increased 31951.2% from $334K to $107.2M. The office’s share of positive obligations moved from 0.020% to 6.2%, a change of +6.2 percentage points.

    The latest period contains 17 actions across 16 awards and 3 newly active prime contractors. The preceding period contained 5 active prime contractors and 11 awards.

    Leading award-level changes

  6. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIDA

    #6Down 1 from #5

    Latest 12 months

    $75.9M

    4.4% of positive obligations

    Versus preceding 12 months

    +$1.3M

    34 active prime contractors · 84 awards

    View office comparison and evidence

    Reported obligations increased 1.7% from $74.6M to $75.9M. The office’s share of positive obligations moved from 4.7% to 4.4%, a change of −0.3 percentage points.

    The latest period contains 111 actions across 84 awards and 11 newly active prime contractors. The preceding period contained 33 active prime contractors and 93 awards.

  7. Reported funding office

    BARDA - ASPR / DAAPPO / BARDA DCMA

    #7Down 3 from #4

    Latest 12 months

    $56.5M

    3.3% of positive obligations

    Versus preceding 12 months

    −$39.5M

    21 active prime contractors · 29 awards

    View office comparison and evidence

    Reported obligations decreased 41.1% from $96.0M to $56.5M. The office’s share of positive obligations moved from 6.0% to 3.3%, a change of −2.8 percentage points.

    The latest period contains 62 actions across 29 awards and 4 newly active prime contractors. The preceding period contained 30 active prime contractors and 39 awards.

  8. Reported funding office

    NATIONAL INSTITUTE OF HEALTH NIEHS

    #8Up 1 from #9

    Latest 12 months

    $44.1M

    2.5% of positive obligations

    Versus preceding 12 months

    +$9.4M

    7 active prime contractors · 9 awards

    View office comparison and evidence

    Reported obligations increased 27.3% from $34.6M to $44.1M. The office’s share of positive obligations moved from 2.2% to 2.5%, a change of +0.4 percentage points.

    The latest period contains 23 actions across 9 awards and 3 newly active prime contractors. The preceding period contained 6 active prime contractors and 7 awards.

  9. Reported funding office

    ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)

    #9Up 1 from #10

    Latest 12 months

    $32.0M

    1.9% of positive obligations

    Versus preceding 12 months

    +$14.2M

    21 active prime contractors · 24 awards

    View office comparison and evidence

    Reported obligations increased 79.6% from $17.8M to $32.0M. The office’s share of positive obligations moved from 1.1% to 1.9%, a change of +0.7 percentage points.

    The latest period contains 40 actions across 24 awards and 8 newly active prime contractors. The preceding period contained 20 active prime contractors and 22 awards.

  10. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NICHD

    #10Down 2 from #8

    Latest 12 months

    $26.9M

    1.6% of positive obligations

    Versus preceding 12 months

    −$8.2M

    16 active prime contractors · 48 awards

    View office comparison and evidence

    Reported obligations decreased 23.3% from $35.1M to $26.9M. The office’s share of positive obligations moved from 2.2% to 1.6%, a change of −0.7 percentage points.

    The latest period contains 74 actions across 48 awards and 3 newly active prime contractors. The preceding period contained 24 active prime contractors and 85 awards.

  11. Reported funding office

    CDC OFFICE OF ACQUISITION SERVICES

    #11Down 4 from #7

    Latest 12 months

    $23.7M

    1.4% of positive obligations

    Versus preceding 12 months

    −$36.9M

    66 active prime contractors · 97 awards

    View office comparison and evidence

    Reported obligations decreased 60.9% from $60.6M to $23.7M. The office’s share of positive obligations moved from 3.8% to 1.4%, a change of −2.4 percentage points.

    The latest period contains 132 actions across 97 awards and 23 newly active prime contractors. The preceding period contained 85 active prime contractors and 124 awards.

  12. Reported funding office

    NATIONAL INSTITUTES OF HEALTH NIA

    #27Down 15 from #12

    Latest 12 months

    $2.0M

    0.12% of positive obligations

    Versus preceding 12 months

    −$13.3M

    7 active prime contractors · 7 awards

    View office comparison and evidence

    Reported obligations decreased 86.8% from $15.4M to $2.0M. The office’s share of positive obligations moved from 0.97% to 0.12%, a change of −0.8 percentage points.

    The latest period contains 7 actions across 7 awards and 3 newly active prime contractors. The preceding period contained 9 active prime contractors and 11 awards.

Contract types, competition, and procurement methods

From Sep 11, 2025 through Sep 10, 2026, 516 awards had positive obligations totaling $2.0B. Np was the leading reported procedure, accounting for 45.7% of positive obligations. Awards with a reported parent IDV accounted for 72.1%. Reported awards used contract vehicles such as SEER, CTSU, and WHI Regional Centers.

Leading award type
72.1%
Delivery Order
Leading reported procedure
45.7%
Np
Reported parent IDV
72.1%
of positive obligations had a reported parent IDV
Median reported offers
2
284 of 516 awards reported offers

Observed contract vehicles

Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.

  • SEER

    $42.2M

    2.1% of positive obligations · 20 matched awards

  • CTSU

    $24.2M

    1.2% of positive obligations · 4 matched awards

  • WHI Regional Centers

    $17.1M

    0.87% of positive obligations · 4 matched awards

Buying method changes

Compared with Sep 11, 2024–Sep 10, 2025. Based on 516 current awards and 584 preceding awards with positive net obligations.

Reported full-and-open obligation share
36.7%
Down from 80.6% in the preceding period
How to read these changes

Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.

Same-NAICS comparison

Compared with the NAICS 541715 peer median, parent-IDV obligation share is 8.8 percentage points higher, reported full-and-open obligation share is 26.7 percentage points higher, delivery-order obligation share is 8.8 percentage points higher, and median positive award obligations are 227.0% higher.

MeasureThis marketPeer medianDifference
Parent-IDV obligation share72.1%63.3%+8.8 pts
Reported full-and-open obligation share36.7%10.0%+26.7 pts
Delivery-order obligation share72.1%63.3%+8.8 pts
Median positive award obligations$920K$281K+227.0%
Peer cohort and comparison limits

The peer median gives each of the 9 eligible agency markets equal weight. The included agency markets are:

Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.

View buying-method details and data coverage

Award types

Reported valueAwardsPositive obligationsShare
Delivery Order(C)332$1.4B72.1%
Definitive Contract(D)146$543.5M27.6%
Purchase Order(B)38$5.7M0.29%

Reported parent-award types

Reported valueAwardsPositive obligationsShare
IDC(B)330$1.4B72.0%
FSS(C)2$798K0.040%
Not reported184$549.2M27.9%

Single- or multiple-award parent structure

Reported valueAwardsPositive obligationsShare
Single Award(S)232$1.3B66.1%
Multiple Award(M)100$117.5M6.0%
Not reported184$549.2M27.9%

Solicitation procedures

Reported valueAwardsPositive obligationsShare
Np(NEGOTIATED PROPOSAL/QUOTE)97$898.8M45.7%
Negotiated Proposal/Quote(NP)211$696.3M35.4%
Only One Source(SSS)49$139.8M7.1%
Sss(ONLY ONE SOURCE)18$92.1M4.7%
Subject to Multiple Award Fair Opportunity(MAFO)69$67.4M3.4%
Mafo(SUBJECT TO MULTIPLE AWARD FAIR OPPORTUNITY)31$50.2M2.5%
Other reported values41$22.3M1.1%

Extent competed

Reported valueAwardsPositive obligationsShare
A(FULL AND OPEN COMPETITION)114$920.0M46.8%
Full and Open Competition(A)252$721.1M36.7%
Not Competed(C)41$118.0M6.0%
C(NOT COMPETED)18$92.1M4.7%
Full and Open Competition After Exclusion of Sources(D)33$57.0M2.9%
D(FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES)14$28.9M1.5%
Other reported values44$29.7M1.5%

Fair-opportunity and limited-source reporting

Reported valueAwardsPositive obligationsShare
Fair Opportunity Given(FAIR)77$104.9M5.3%
Follow-on Action Following Competitive Initial Action(FOO)15$8.5M0.43%
Competitive Set Aside(CSA)3$3.3M0.17%
Only One Source - Other(ONE)3$637K0.030%
Other Statutory Authority(OSA)2$178K0.010%
Not reported416$1.8B94.0%

Other-than-full-and-open reasons

Reported valueAwardsPositive obligationsShare
Mobilization, Essential R&d (FAR 6.302-3)(MES)35$157.7M8.0%
Only One Source-Other (FAR 6.302-1 Other)(ONE)23$50.2M2.5%
Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH)11$25.0M1.3%
SAP Non-Competition (FAR 13)(SP2)15$2.3M0.12%
Unsolicited Research Proposal (FAR 6.302-1(A)(2)(I))(UR)1$2.1M0.11%
Not reported431$1.7B87.9%

Contract pricing types

Reported valueAwardsPositive obligationsShare
U(COST PLUS FIXED FEE)59$848.4M43.1%
Cost Plus Fixed Fee(U)149$604.0M30.7%
Cost No Fee(S)102$186.0M9.5%
S(COST NO FEE)40$119.5M6.1%
Firm Fixed Price(J)83$87.7M4.5%
T(COST SHARING)13$37.2M1.9%
Other reported values70$83.9M4.3%

Product or Service Codes

Reported valueAwardsPositive obligationsShare
Health R&d Services; Health Care Services; Applied Research(AN12)242$1.4B70.6%
Health R&d Services; Health Care Services; Basic Research(AN11)98$230.2M11.7%
Health R&d Services; Health Care Services; Experimental Development(AN13)18$83.8M4.3%
Support- Professional: Other(R499)33$65.9M3.4%
General Science and Technology R&d Services; General Science and Technology; Applied Research(AJ12)12$35.6M1.8%
General Science and Technology R&d Services; General Science and Technology; Basic Research(AJ11)17$33.9M1.7%
Other reported values96$129.6M6.6%

Awarding subagencies

Reported valueAwardsPositive obligationsShare
National Institutes of Health(7529)393$1.7B85.6%
Centers for Medicare and Medicaid Services(7530)15$127.7M6.5%
Office of Assistant Secretary for Preparedness and Response(7505)13$58.9M3.0%
Centers for Disease Control and Prevention(7523)28$31.9M1.6%
Food and Drug Administration(7524)26$21.4M1.1%
Departmental Offices(1406)9$16.5M0.84%
Other reported values32$27.5M1.4%

Awarding offices

Reported valueAwardsPositive obligationsShare
Nih Nci(75N910)102$1.0B52.0%
National Institutes of Health Niaid(75N930)89$302.9M15.4%
Ofc of Acquisition and Grants Mgmt(75FCMC)15$127.7M6.5%
National Institutes of Health Nhlbi(75N920)60$109.1M5.5%
National Institutes of Health Nida(75N950)43$95.3M4.8%
National Institutes of Health Olao(75N980)48$61.4M3.1%
Other reported values159$247.7M12.6%

Reported parent IDVs

Reported valueAwardsPositive obligationsShare
75N91019D00024(7529)53$911.4M46.3%
75FCMC23D0004(7530)30$152.3M7.8%
75N91022D00009(7529)2$22.2M1.1%
75N93020D00011(7529)2$17.7M0.90%
75N92024D00013(7529)4$13.1M0.66%
75N92021D00001(7529)1$10.2M0.52%
75N92023D00011(7529)2$10.2M0.52%
75N92025D00037(7529)2$9.9M0.50%
Other reported values236$270.5M13.8%
Not reported184$549.2M27.9%

Exact vehicle-match evidence

Reported award data linked 30 awards to a specific catalog vehicle.

Offers, award size, and timing

Median reported offers
2 median
284 reported · 232 not reported
Positive award obligations
$920K median
$297K–$2.9M middle 50%
Reported performance period
910 days (~2.5 years) median
516 reported · 0 not reported

Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Sep 10, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.

Top federal contractors

Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.

Prime contractor concentration
35 of 227prime contractors account for at least 80% of positive obligations in the last 12 months
Largest prime contractor
40.2%of positive obligations in the last 12 months
Leading four prime contractors
56.5%of positive obligations in the last 12 months
Leading eight prime contractors
61.9%of positive obligations in the last 12 months

Based on $1.7B in positive obligations during the 12 months ending Sep 10, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Sep 11, 2024–Sep 10, 2025.

Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.

15 leading contractors
  1. #1

    Last 12mo obligations

    $701.6M

    40.2%

    Dollar movement

    +$128.8M

    vs. prior 12 months

    Last 12mo awards

    111 awards

    168 actions

    Historical and award details for LEIDOS BIOMEDICAL RESEARCH INC
    Obligations: prior → latest
    $572.7M → $701.6M
    +22.5%
    Share: prior → latest
    35.6% → 40.2%
    +4.5 percentage points
    All-period obligations
    $3.7B
    37.8% of all-period positive obligations · 174 awards
    Recorded activity
    Since Oct 27, 2021
    through Sep 9, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside00
    Not reported111105
    Reported small business00
    All-period set-aside types

    None reported.

  2. #2

    Last 12mo obligations

    $151.1M

    8.7%

    Dollar movement

    +$6.6M

    vs. prior 12 months

    Last 12mo awards

    39 awards

    79 actions

    Historical and award details for THE MITRE CORPORATION
    Obligations: prior → latest
    $144.5M → $151.1M
    +4.6%
    Share: prior → latest
    9.0% → 8.7%
    −0.3 percentage points
    All-period obligations
    $328.4M
    3.3% of all-period positive obligations · 62 awards
    Recorded activity
    Since Sep 27, 2023
    through Sep 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported3948
    Reported small business00
    All-period set-aside types

    None reported.

  3. #3

    Last 12mo obligations

    $86.7M

    5.0%

    Dollar movement

    +$18.5M

    vs. prior 12 months

    Last 12mo awards

    15 awards

    27 actions

    Historical and award details for WESTAT, INC.
    Obligations: prior → latest
    $68.1M → $86.7M
    +27.2%
    Share: prior → latest
    4.2% → 5.0%
    +0.7 percentage points
    All-period obligations
    $284.4M
    2.9% of all-period positive obligations · 47 awards
    Recorded activity
    Since Oct 14, 2021
    through Sep 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside12
    Not reported1422
    Reported small business00
    All-period set-aside types

    None reported.

  4. #4

    Last 12mo obligations

    $46.8M

    2.7%

    Dollar movement

    +$774K

    vs. prior 12 months

    Last 12mo awards

    10 awards

    14 actions

    Historical and award details for TECHNICAL RESOURCES INTERNATIONAL, INC.
    Obligations: prior → latest
    $46.1M → $46.8M
    +1.7%
    Share: prior → latest
    2.9% → 2.7%
    −0.2 percentage points
    All-period obligations
    $187.2M
    1.9% of all-period positive obligations · 18 awards
    Recorded activity
    Since Oct 28, 2021
    through Aug 25, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside22
    Reported no set-aside33
    Not reported57
    Reported small business1012
    All-period set-aside types
    • 3 · Total small business
  5. #5

    Last 12mo obligations

    $28.5M

    1.6%

    Dollar movement

    −$4.2M

    vs. prior 12 months

    Last 12mo awards

    20 awards

    34 actions

    Historical and award details for DUKE UNIVERSITY
    Obligations: prior → latest
    $32.7M → $28.5M
    −13.0%
    Share: prior → latest
    2.0% → 1.6%
    −0.4 percentage points
    All-period obligations
    $195.9M
    2.0% of all-period positive obligations · 49 awards
    Recorded activity
    Since Oct 12, 2021
    through Sep 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside911
    Not reported1119
    Reported small business00
    All-period set-aside types

    None reported.

  6. #6

    Last 12mo obligations

    $24.1M

    1.4%

    Dollar movement

    +$524K

    vs. prior 12 months

    Last 12mo awards

    8 awards

    14 actions

    Historical and award details for AMERICAN TYPE CULTURE COLLECTION
    Obligations: prior → latest
    $23.6M → $24.1M
    +2.2%
    Share: prior → latest
    1.5% → 1.4%
    −0.1 percentage points
    All-period obligations
    $167.4M
    1.7% of all-period positive obligations · 20 awards
    Recorded activity
    Since Oct 14, 2021
    through Sep 2, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported68
    Reported small business00
    All-period set-aside types

    None reported.

  7. #7

    Last 12mo obligations

    $21.9M

    1.3%

    Dollar movement

    +$1.8M

    vs. prior 12 months

    Last 12mo awards

    16 awards

    27 actions

    Historical and award details for THE JOHNS HOPKINS UNIVERSITY
    Obligations: prior → latest
    $20.0M → $21.9M
    +9.2%
    Share: prior → latest
    1.3% → 1.3%
    0.0 percentage points
    All-period obligations
    $82.1M
    0.83% of all-period positive obligations · 55 awards
    Recorded activity
    Since Oct 13, 2021
    through Sep 3, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside44
    Not reported1225
    Reported small business00
    All-period set-aside types

    None reported.

  8. #8

    Last 12mo obligations

    $21.2M

    1.2%

    Dollar movement

    −$1.7M

    vs. prior 12 months

    Last 12mo awards

    27 awards

    38 actions

    Historical and award details for SRI INTERNATIONAL
    Obligations: prior → latest
    $22.9M → $21.2M
    −7.4%
    Share: prior → latest
    1.4% → 1.2%
    −0.2 percentage points
    All-period obligations
    $100.1M
    1.0% of all-period positive obligations · 65 awards
    Recorded activity
    Since Oct 12, 2021
    through Aug 24, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside23
    Not reported2525
    Reported small business00
    All-period set-aside types

    None reported.

  9. #9

    Last 12mo obligations

    $18.0M

    1.0%

    Dollar movement

    +$1.1M

    vs. prior 12 months

    Last 12mo awards

    1 award

    7 actions

    Historical and award details for BATTELLE MEMORIAL INSTITUTE
    Obligations: prior → latest
    $16.9M → $18.0M
    +6.7%
    Share: prior → latest
    1.1% → 1.0%
    0.0 percentage points
    All-period obligations
    $34.9M
    0.35% of all-period positive obligations · 2 awards
    Recorded activity
    Since Mar 16, 2022
    through Sep 3, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside11
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  10. #10

    Last 12mo obligations

    $17.3M

    0.99%

    Dollar movement

    −$15.0M

    vs. prior 12 months

    Last 12mo awards

    5 awards

    21 actions

    Historical and award details for ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
    Obligations: prior → latest
    $32.3M → $17.3M
    −46.4%
    Share: prior → latest
    2.0% → 0.99%
    −1.0 percentage points
    All-period obligations
    $150.7M
    1.5% of all-period positive obligations · 5 awards
    Recorded activity
    Since Oct 12, 2021
    through Sep 8, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside54
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  11. #11

    Last 12mo obligations

    $16.9M

    0.97%

    Dollar movement

    −$5.5M

    vs. prior 12 months

    Last 12mo awards

    23 awards

    29 actions

    Historical and award details for THE EMMES COMPANY, LLC
    Obligations: prior → latest
    $22.4M → $16.9M
    −24.6%
    Share: prior → latest
    1.4% → 0.97%
    −0.4 percentage points
    All-period obligations
    $136.2M
    1.4% of all-period positive obligations · 72 awards
    Recorded activity
    Since Oct 28, 2021
    through Aug 19, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside22
    Not reported2121
    Reported small business11
    All-period set-aside types
    • 1 · Total small business
  12. #12

    Last 12mo obligations

    $16.5M

    0.94%

    Dollar movement

    +$16.5M

    vs. prior 12 months

    Last 12mo awards

    1 award

    2 actions

    Historical and award details for UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Obligations: prior → latest
    $0 → $16.5M
    Not comparable
    Share: prior → latest
    0% → 0.94%
    +0.9 percentage points
    All-period obligations
    $38.0M
    0.38% of all-period positive obligations · 4 awards
    Recorded activity
    Since May 24, 2022
    through Aug 28, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business00
    All-period set-aside types

    None reported.

  13. #13

    Last 12mo obligations

    $15.1M

    0.86%

    Dollar movement

    −$36K

    vs. prior 12 months

    Last 12mo awards

    4 awards

    6 actions

    Historical and award details for FRED HUTCHINSON CANCER CENTER
    Obligations: prior → latest
    $15.1M → $15.1M
    −0.2%
    Share: prior → latest
    0.94% → 0.86%
    −0.1 percentage points
    All-period obligations
    $58.5M
    0.59% of all-period positive obligations · 10 awards
    Recorded activity
    Since Jul 12, 2022
    through Aug 31, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside01
    Not reported44
    Reported small business00
    All-period set-aside types

    None reported.

  14. #14

    Last 12mo obligations

    $15.0M

    0.86%

    Dollar movement

    +$15.0M

    vs. prior 12 months

    Last 12mo awards

    1 award

    1 action

    Historical and award details for FLOSONICS MEDICAL LLC
    Obligations: prior → latest
    $0 → $15.0M
    Not comparable
    Share: prior → latest
    0% → 0.86%
    +0.9 percentage points
    All-period obligations
    $15.0M
    0.15% of all-period positive obligations · 1 award
    Recorded activity
    Since Jun 5, 2026
    through Jun 5, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside10
    Not reported00
    Reported small business10
    All-period set-aside types

    None reported.

  15. #15

    Last 12mo obligations

    $14.6M

    0.83%

    Dollar movement

    +$5.3M

    vs. prior 12 months

    Last 12mo awards

    5 awards

    10 actions

    Historical and award details for BIOQUAL, INC.
    Obligations: prior → latest
    $9.3M → $14.6M
    +56.8%
    Share: prior → latest
    0.58% → 0.83%
    +0.3 percentage points
    All-period obligations
    $54.8M
    0.55% of all-period positive obligations · 8 awards
    Recorded activity
    Since Jan 28, 2022
    through Sep 4, 2026

    Award reporting

    Latest and prior 12-month award reporting
    Reported award evidenceLatestPrior
    Reported set-aside00
    Reported no set-aside12
    Not reported46
    Reported small business47
    All-period set-aside types

    None reported.

Potential federal contract recompetes

Investigate potential recompetes surfaced by near-term end dates, award value, and recent contract changes.

SAFESOURCE DIRECT LLC

EO 14398; INDUSTRIAL BASE EXPANSION OF NITRILE GLOVES MANUFACTURING

The reported potential end date is Dec 15, 2026. Current award value is 100.0% of reported potential value ($144.8M of $144.8M).

Performance period

91.8%

As of Sep 10, 2026Potential end Dec 15, 2026

Current award value as a share of potential value

100.0%

$144.8M current$144.8M potential
Supporting data

Reported performance starts Sep 30, 2023.

No later potential end date is reported; current and potential end dates are both Dec 15, 2026.

$144.8M is obligated against $144.8M in current reported award value (100.0%).

Reported potential end dates: Sep 29, 2025 → Jun 30, 2026 → Dec 15, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50223C00024

ASCEND PERFORMANCE MATERIALS TEXAS INC

DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE BUTADIENE RUBBER (NBR)

The reported potential end date is Sep 26, 2026. Current award value is 100.0% of reported potential value ($87.7M of $87.7M).

Performance period

98.5%

As of Sep 10, 2026Potential end Sep 26, 2026

Current award value as a share of potential value

100.0%

$87.7M current$87.7M potential
Supporting data

Reported performance starts Nov 1, 2023.

No later potential end date is reported; current and potential end dates are both Sep 26, 2026.

$87.7M is obligated against $87.7M in current reported award value (100.0%).

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50424C00002

LEIDOS BIOMEDICAL RESEARCH INC

EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)

The reported potential end date is Oct 31, 2026. Current award value is 100.0% of reported potential value ($79.9M of $79.9M).

Performance period

97.6%

As of Sep 10, 2026Potential end Oct 31, 2026

Current award value as a share of potential value

100.0%

$79.9M current$79.9M potential
Supporting data

Reported performance starts Feb 10, 2021.

No later potential end date is reported; current and potential end dates are both Oct 31, 2026.

$79.9M is obligated against $79.9M in current reported award value (100.0%).

Reported potential end dates: Feb 10, 2026 → Oct 31, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75N91021F00001

QYK BRANDS LLC

INDUSTRIAL BASE EXPANSION (IBX) FOR METHACRYLIC ACID FOR KEY CHEMICALS.

The reported potential end date is Dec 15, 2026. Current award value is 100.0% of reported potential value ($48.3M of $48.3M).

Performance period

91.2%

As of Sep 10, 2026Potential end Dec 15, 2026

Current award value as a share of potential value

100.0%

$48.3M current$48.3M potential
Supporting data

Reported performance starts Dec 18, 2023.

No later potential end date is reported; current and potential end dates are both Dec 15, 2026.

$48.3M is obligated against $48.3M in current reported award value (100.0%).

Reported potential end dates: Aug 17, 2026 → Dec 15, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50424C00001

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

EO 14398 - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS)

The reported potential end date moved later 3 times in the latest 12 months.

Performance period

89.4%

As of Sep 10, 2026Potential end Jul 9, 2027

Current award value as a share of potential value

73.9%

$111.2M current$150.5M potential
Supporting data

Reported performance starts Sep 10, 2019.

No later potential end date is reported; current and potential end dates are both Jul 9, 2027.

$111.2M is obligated against $111.2M in current reported award value (100.0%).

Reported potential end dates: Aug 4, 2025 → Sep 14, 2025 → Feb 6, 2026 → Aug 14, 2026 → Sep 24, 2026 → Feb 28, 2027 → Jun 1, 2027 → Jul 9, 2027.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75N93019C00051

PHILIPS NORTH AMERICA LLC

THE PURPOSE OF THIS MODIFICATION IS TO: 1. CLIN 0001: DECREASE THE TOTAL AMOUNT FUNDED FROM $34,892,573.62 BY $459.74 TO $34,893,033.36. 2. THE TOTAL CONTRACT VALUE IS HEREBY DECREASED FROM $68,167,100.36 BY $459.74 TO $68,166,640.62.

The reported potential end date is Dec 31, 2026. Current award value is 100.0% of reported potential value ($68.2M of $68.2M).

Performance period

95.4%

As of Sep 10, 2026Potential end Dec 31, 2026

Current award value as a share of potential value

100.0%

$68.2M current$68.2M potential
Supporting data

Reported performance starts May 8, 2020.

No later potential end date is reported; current and potential end dates are both Dec 31, 2026.

$68.2M is obligated against $68.2M in current reported award value (100.0%).

Reported potential end dates: May 31, 2025 → May 31, 2024 → May 31, 2025 → Dec 31, 2026.

Obligations are compared with current reported award value, not treated as a contract ceiling.

PIID 75A50120C00097

These are research leads, not confirmed recompetes. USAspending records through Sep 10, 2026; reported dates and values can change through later modifications.

Recent federal contract award activity

Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.

Modification

This action

+$271.0M

LEIDOS BIOMEDICAL RESEARCH INC

NIH NCI

NCI OPERATIONAL TASK ORDER, FY26-FY27

Why it stands out

This award grew while spending attributed to its office declined.

The modification added $271.0M while office-attributed obligations fell $65.9M overall.

Award net obligations
$485.5M
Share of 12-month positive obligations
15.5%
Supporting data
Prime contractor
#1 · 40.2% share
+4.5 percentage points · $128.8M net increase; action exceeded it by $142.2M
Funding office
#1 · 37.0% attributed share
$65.9M net decline despite this positive action
Related:Unusually large actionLargest contractor gain
PIID 75N91025F00016 · Mod P00001
Modification

This action

+$102.8M

LEIDOS BIOMEDICAL RESEARCH INC

NATIONAL INSTITUTES OF HEALTH NCATS

ADVANCE UNIVERSAL INFLUENZA VACCINE - FLU MOSAIC VERSION 2 (FLUMOSV2)

Why it stands out

The award grew alongside stronger office-attributed spending.

The modification added $102.8M while office-attributed obligations rose $106.8M overall.

Award net obligations
$141.7M
Share of 12-month positive obligations
5.9%
Supporting data
Funding office
#5 · 6.2% attributed share
up 26 ranks · +6.2 percentage points · $106.8M net increase; action accounted for 96.2%
Related:Funding office gain
PIID 75N91021F00004 · Mod P00009
Deobligation

This action

−$63.7M

LEIDOS BIOMEDICAL RESEARCH INC

NIH NCI

EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::CENTER FOR SEROLOGICAL SCIENCES NETWORK (SERONET)

Why it stands out

The award contracted while the contractor grew overall.

The action removed $63.7M while the contractor rose $128.8M.

Award net obligations
$79.9M
Share of 12-month positive obligations
3.6%
Supporting data
Prime contractor
#1 · 40.2% share
$128.8M net increase despite this negative action
Funding office
#1 · 37.0% attributed share
−7.5 percentage points · $65.9M net decline; action accounted for 96.7%
Related:Unusually large actionFunding office decline
PIID 75N91021F00001 · Mod P00010
Modification

This action

+$47.8M

WESTAT, INC.

NATIONAL INSTITUTES OF HEALTH NIDA

POPULATION ASSESSMENT OF TOBACCO AND HEALTH (PATH) STUDY PERIOD OF PERFORMANCE: 02/01/2024 - 11/30/2030.

Why it stands out

The award grew alongside stronger contractor activity.

The modification added $47.8M while contractor obligations rose $18.5M overall.

Award net obligations
$85.5M
Share of 12-month positive obligations
2.7%
Supporting data
Prime contractor
#3 · 5.0% share
+0.7 percentage points · $18.5M net increase; action exceeded it by $29.3M
PIID 75N95024C00003 · Mod P00009

BARDA - ASPR / DAAPPO / BARDA DCMA

ADD ADDITIONAL FUNDING TO THE BASE PERIOD; UPDATE COA THRESHOLD TO $350,000; ADD BERYL VOIGT AS ALTERNATE COR; UPDATE FAR/HHSAR CLAUSES PER EXECUTIVE ORDERS AND REVOLUTIONARY FAR/HHSAR OVERHAUL (RFO); UPDATE SOW AND CONTRACT MILESTONES AND DELIVERABL

Why it stands out

No activity for this contractor was reported in this market during the preceding 12 months.

The modification placed the contractor #12 in this market by positive obligations over the latest 12 months.

Award net obligations
$37.6M
Share of 12-month positive obligations
0.94%
Supporting data
Prime contractor
#12 · 0.94% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#7 · 3.3% attributed share
$39.5M net decline despite this positive action
PIID 75A50123C00047 · Mod P00002
Base award

This action

+$15.0M

FLOSONICS MEDICAL LLC

BARDA - ASPR / DAAPPO / BARDA DCMA

THE PURPOSE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF FLOPATCH FP120 WITH FLOPREDICT ALERT FOR BURN AND BLAST MEDICAL COUNTERMEASURE AND INCORPORATES EO 14398.

Why it stands out

No activity for this contractor was reported in this market during the preceding 12 months.

The base action placed the contractor #14 in this market by positive obligations over the latest 12 months.

Award net obligations
$15.0M
Share of 12-month positive obligations
0.86%
Supporting data
Prime contractor
#14 · 0.86% share
Newly active in this market; no actions were reported in the preceding 12 months
Funding office
#7 · 3.3% attributed share
$39.5M net decline despite this positive action
PIID 75A50126C00006
View recent award activity by date (10)
  1. LEIDOS BIOMEDICAL RESEARCH INCDeobligation · PIID 75N91020F00039
    Action−$74.5M
    Award net obligations$159.1M
  2. OCEANIT LABORATORIES INCBase award · PIID 140D0426C0101
    Action+$3.5M
    Award net obligations$3.5M
  3. ELECTRONIC BIOSCIENCES, INC.Base award · PIID 140D0426C0135
    Action+$3.0M
    Award net obligations$3.0M
  4. WASHINGTON UNIVERSITY, THEModification · PIID 75N95024C00027
    Action+$2.6M
    Award net obligations$6.3M
  5. TEXAS A & M UNIVERSITYBase award · PIID 75D30126P21549
    Action+$336K
    Award net obligations$336K
  6. THE RAND CORPORATIONModification · PIID 75Q80125F32001
    Action+$90K
    Award net obligations$180K
  7. CLOVERLEAF BIO, INC.Deobligation · PIID 75N91025C00020
    Action−$55K
    Award net obligations$300K
  8. SYZONC, INCDeobligation · PIID 75N91025C00027
    Action−$55K
    Award net obligations$300K
  9. COLORADO STATE UNIVERSITYDeobligation · PIID 75N93021F00003
    Action−$33K
    Award net obligations$326K
  10. UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTONDeobligation · PIID 75N93021F00003
    Action−$25K
    Award net obligations$348K

HHS NAICS 541715 market FAQs

Answers based on reported federal contract data.

Who are the top HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) contractors?

In the 12 months through September 10, 2026, LEIDOS BIOMEDICAL RESEARCH INC, THE MITRE CORPORATION, and WESTAT, INC. were the leading HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) prime contractors by positive obligations.

  1. #1

    LEIDOS BIOMEDICAL RESEARCH INC

    $701,565,322 in positive obligations

  2. #2

    THE MITRE CORPORATION

    $151,145,718 in positive obligations

  3. #3

    WESTAT, INC.

    $86,657,960 in positive obligations

Rankings use reported USAspending award data.

Did HHS contract obligations increase under NAICS 541715?

Yes. Measured by net prime contract obligations, reported HHS activity in the research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) market increased 8.9% from $1,591,741,078 in the preceding 12 months to $1,733,818,790 in the 12 months through September 10, 2026.

Latest 12 months
$1,733,818,790
Net prime contract obligations
Preceding 12 months
$1,591,741,078
Net prime contract obligations
Change
+8.9%
Between matched 12-month periods

Reported contract actions, not outlays or a forecast.

What recent HHS contract award activity was reported under NAICS 541715?

Recent HHS contract award activity reported in the research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) market included actions for LEIDOS BIOMEDICAL RESEARCH INC, WESTAT, INC., and UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION during the 12 months through September 10, 2026.

Action obligations are transaction-level amounts, not current award-level obligations.

Which procurement methods were reported for HHS contracts under NAICS 541715?

From September 11, 2025 through September 10, 2026, HHS reported 516 positive-obligation awards for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) under NAICS 541715. The leading award type was delivery order. The leading reported procedure was np.

Positive-obligation awards
516
Leading reported procedure
Np
45.7% of positive obligations
Leading award type
Delivery Order
72.1% of positive obligations
Full and open
36.7%
of positive obligations
Reported parent IDV
72.1%
of positive obligations
Observed vehicles
SEER, CTSU, and WHI Regional Centers
Exact matches from reported parent PIIDs

Percentages use positive obligations as the denominator.

Which HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) awards may warrant recompete research?

6 HHS research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) awards may warrant recompete research based on reported potential-end dates, including awards held by SAFESOURCE DIRECT LLC, ASCEND PERFORMANCE MATERIALS TEXAS INC, and LEIDOS BIOMEDICAL RESEARCH INC.

Research leads, not confirmed recompetes. Dates may change through later modifications.

Apply this research to a live pursuit

Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.

See Sweetspot in action

Related market research

Complete market indexes:

Same NAICS at other agencies:

Nearby NAICS at this agency:

Markets sharing leading prime records:

Leading-prime vehicle memberships:

Company memberships do not establish award-channel use.

Reported obligations include contract actions from October 1, 2021 through September 10, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.

Review data methodology